RB

Director Director DIN 08627876
DIN 08627876 First appointment Dec 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2019
Shareholding value •••• Premium profile

About Rani Bala

Data last updated:

Rani Bala was a Director at Invipro Pharmaceuticals Private Limited (2022–2024) and Director at Galveston Healthcare Private Limited (2019–2020). The companies operate in Chemicals and Pharma.

DIN 08627876
Primary Designation Director
Industry Chemicals
First Appointment 03 Dec 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Sep 20222022₹25.4 Lakh (FY 2024)Active
Galveston Healthcare Private Limited U85300UP2017PTC092066
Director03 Dec 20192017₹2.44 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Invipro Pharmaceuticals Private Limited
Galveston Healthcare Private Limited
Premium access

Shareholding and investment profile for Rani Bala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rani Bala

Rani Bala was first appointed on 03 Dec 2019 as Director at Galveston Healthcare Private Limited. The most recent appointment on record is 20 Sep 2022 at Invipro Pharmaceuticals Private Limited.

Rani Bala held 2 earlier board appointments: Invipro Pharmaceuticals Private Limited (Director, 20 Sep 2022 to 17 Jul 2024); Galveston Healthcare Private Limited (Director, 03 Dec 2019 to 25 May 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available